Scientists are advancing a promising new way to fight antibiotic-resistant infections by using viruses that specifically target and kill harmful bacteria. An international team has released the first coordinated guidelines for personalized phage therapy, offering a roadmap for safely bringing this experimental treatment into clinical practice. Early findings are encouraging, with one study reporting improvement in 77% of patients and the disappearance of targeted bacteria in 61%.